Alan D. Diamond

Array ( [id] => 19953966 [patent_doc_number] => RE050453 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-06-10 [patent_title] => Indole derivatives as CFTR modulators [patent_app_type] => reissue [patent_app_number] => 18/089898 [patent_app_country] => US [patent_app_date] => 2022-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63499 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18089898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19953968 [patent_doc_number] => RE050455 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-06-10 [patent_title] => Pyrazolopyridine derivative having GLP-1 receptor agonist effect [patent_app_type] => reissue [patent_app_number] => 18/077060 [patent_app_country] => US [patent_app_date] => 2022-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 31530 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18077060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20106174 [patent_doc_number] => RE050490 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-07-15 [patent_title] => Substituted quinazoline compounds and methods of use thereof [patent_app_type] => reissue [patent_app_number] => 17/985017 [patent_app_country] => US [patent_app_date] => 2022-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 55354 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 378 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17985017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19807669 [patent_doc_number] => RE050319 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-03-04 [patent_title] => Compounds and methods for treating cancer [patent_app_type] => reissue [patent_app_number] => 17/984910 [patent_app_country] => US [patent_app_date] => 2022-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14434 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17984910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20576626 [patent_doc_number] => RE050811 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2026-03-10 [patent_title] => Rapid imaging systems and methods for facilitating rapid radiation therapies [patent_app_type] => reissue [patent_app_number] => 17/969338 [patent_app_country] => US [patent_app_date] => 2022-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 23 [patent_no_of_words] => 9697 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17969338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20384751 [patent_doc_number] => RE050681 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-12-02 [patent_title] => Ionizable cationic lipid for RNA delivery [patent_app_type] => reissue [patent_app_number] => 17/958932 [patent_app_country] => US [patent_app_date] => 2022-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6680 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17958932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19272644 [patent_doc_number] => RE050031 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-07-02 [patent_title] => Chemical formulations for electrochemical device [patent_app_type] => reissue [patent_app_number] => 17/950044 [patent_app_country] => US [patent_app_date] => 2022-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 7595 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17950044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20451096 [patent_doc_number] => RE050748 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2026-01-06 [patent_title] => Organic electroluminescence device [patent_app_type] => reissue [patent_app_number] => 17/941844 [patent_app_country] => US [patent_app_date] => 2022-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 15962 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 1868 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19338086 [patent_doc_number] => RE050063 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-07-30 [patent_title] => Fluoropolymer compositions with improved mechanical dampening [patent_app_type] => reissue [patent_app_number] => 17/901938 [patent_app_country] => US [patent_app_date] => 2022-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8704 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 216 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17901938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19776813 [patent_doc_number] => RE050301 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-02-18 [patent_title] => Depot systems comprising glatiramer or pharmacologically acceptable salt thereof [patent_app_type] => reissue [patent_app_number] => 17/894447 [patent_app_country] => US [patent_app_date] => 2022-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11321 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17894447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20546949 [patent_doc_number] => RE050805 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2026-02-24 [patent_title] => Single-layer oral dose of neuro-attenuating ketamine [patent_app_type] => reissue [patent_app_number] => 17/886944 [patent_app_country] => US [patent_app_date] => 2022-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5256 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17886944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19665426 [patent_doc_number] => RE050250 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-12-31 [patent_title] => Process for the preparation of cis-alpha,beta substituted cyclopentanones [patent_app_type] => reissue [patent_app_number] => 17/866170 [patent_app_country] => US [patent_app_date] => 2022-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4971 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17866170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19622265 [patent_doc_number] => RE050230 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-12-10 [patent_title] => Method of treatment of hypoxia inducible factor (HIF)-related conditions [patent_app_type] => reissue [patent_app_number] => 17/824596 [patent_app_country] => US [patent_app_date] => 2022-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 5283 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17824596 [rel_patent_id] =>[rel_patent_doc_number] =>)